All filters
Slidesets
Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition- Anna S. Lok, MD, DSc
Presented at:
HEP DART 2017
Slidesets
Global Strategies to Eliminate Hepatitis B (ICE-HBV)- Peter Revill
Presented at:
HEP DART 2017
Slidesets
The French and European Approach Towards Hepatitis Elimination- Tarik Asselah, MD, PhD
Presented at:
HEP DART 2017
Slidesets
Access to HIV, HBV, and HCV Antiviral Agents Globally- John Martin, PhD
Presented at:
HEP DART 2017
Slidesets
DAA Therapy and Reinfection Among People who Inject Drugs: Forming a Foundation for HCV Elimination- Jason Grebely
Presented at:
HEP DART 2017
Slidesets
Liver Disease in Chinese-perspective from a Hepatologist- George Lau, MBBS, MRCP, FHKCP, FHKAM, MD, FRCP
Presented at:
HEP DART 2017
Slidesets
A Tale of Two Viruses: HBV and HCV Co-infection (not available)- Jake Liang
Presented at:
HEP DART 2017
Slidesets
The Global Burden of Non-alcoholic Steatohepatitis (not available)- Zobair Younossi
Presented at:
HEP DART 2017
Slidesets
Short Duration DAA HCV Therapy: How Short Can We Go?- Shyam Kottilil, MD, PhD
Presented at:
HEP DART 2017
Slidesets
Hepatitis B/C and NASH: Crossroads Between Science and Business (not available)- Geoffrey Meacham
Presented at:
HEP DART 2017
Slidesets
Catch me if you can – tuning immunity for HBV cure (not available)- Ulrike Protzer, MD
Presented at:
HEP DART 2017
Slidesets
Optimizing Infection Systems and Screens and Studying Innate anti-HBV Factors and Mechanisms- Lefteris Michailidis, PhD
Presented at:
HEP DART 2017
Slidesets
Is Host Genome Integrated HBV Relevant? - The Con Perspective- Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Slidesets
Is Host Genome Integrated HBV Relevant? - The Pro Perspective- Christian Brechot
Presented at:
HEP DART 2017
Slidesets
Endpoints and New Targets for Curing Hepatitis B- Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Slidesets
Core Antibody: anti-HBc What is the Core of the Story?- Robert Gish, MD
Presented at:
HEP DART 2017
Slidesets
Targeting the HBV-Macrophage-Stellate cell axis to treat HBV-induced Liver Diseases- Lishan Su
Presented at:
HEP DART 2017
Slidesets
In vivo evaluation of anti-HBV CRISPR/Cas9 therapy in the FRG mouse- Dr. K. Jerome
Presented at:
HEP DART 2017